Search by
On December 18, 2025, BioRender announced that it facilitated a secondary purchase by Dimension Capital at a $900 million valuation.
BioRender is a web-based platform that crafts and shares visually engaging scientific figures for communication and publication purposes.
Osler, Hoskin & Harcourt LLP advised BioRender with a team consisting of Chad Bayne, Gary Marshall and Sahil Chopra (Emerging and High Growth Companies).
Parties
Company
BioRender
Company
Dimension Capital
Deal Type
Financing/InvestmentIndustry
Tech/Computer/ITTransaction
$ 900,000,000Deal Status
ClosedClosing Date
18 December 2025